ADVENZYMES302.20

Advanced Enzyme Tech Ltd.

· Pharma & Health
AnnualQuarterly₹ CrorePeersAARTIPHARMAARTIDRUGSAGARWALEYEAKUMSALIVUSAPLLTDCORONAHCGMcap ₹3,382 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations623.9636.9745.8749.6
Other Income36.733.034.839.0
Total Income660.5670.0780.6788.6
Expenses
+ Cost of Materials Consumed155.5162.0194.3204.8
+ Purchases of Stock-in-Trade0.00.00.00.0
+ Changes in Inventories-10.9-10.1-1.4-12.3
+ Employee Benefit Expense128.4141.5162.3167.1
+ Finance Costs2.93.62.62.4
+ Depreciation & Amortisation35.236.640.140.4
+ Other Expenses146.5149.1161.5166.3
Total Expenses457.6482.6559.4568.8
EBITDA204.5194.4229.1223.6
EBIT169.2157.9189.0183.2
Profit
PBT before Exceptional Items203.0187.4221.2219.8
+ Exceptional Items-15.10.011.411.4
Pretax Income187.8187.4232.5231.2
+ Current Tax56.249.556.456.0
+ Deferred Tax-5.33.92.53.4
Tax Expense50.953.458.959.4
Net Income137.0134.0173.6171.8
+ Net Income — Continuing Ops137.0134.0173.6171.8
+ Other Comprehensive Income9.218.894.889.6
Total Comprehensive Income146.2152.8268.4261.4
Net Income to Common133.3131.1168.7165.9
Minority Interest3.62.94.95.9
Per Share
Basic EPS11.9211.7215.0814.82
Diluted EPS11.9211.7115.0614.81
Other Comprehensive Income — detail
+ Other Comprehensive Income18.894.889.6
+ Items NOT to be Reclassified to P&L-0.2-0.71.31.4
+ Tax on Items NOT to be Reclassified-0.20.30.4
+ Tax on Items NOT to be Reclassified — alt tag-0.1
+ Items to be Reclassified to P&L9.419.393.888.6
Comprehensive Income — Owners of Parent142.6149.9263.5255.4
Comprehensive Income — Non-controlling Interests3.62.95.05.9
Per Share — as-filed variants
Basic EPS — Continuing Operations11.9211.7215.0814.82
Diluted EPS — Continuing Operations11.9211.7115.0614.81
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit479.3485.0552.8557.0
Gross Margin %76.8376.1674.1374.31
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)203.0187.4221.2219.8
− Exceptional Items (reconciliation)-15.10.011.411.4
Net Income Adj (tax-effected)148.0134.0165.1163.3
EPS Adj12.8811.7214.3414.09
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value2.002.002.002.00
Filed Debt Equity0.000.000.000.00
Filed Dscr0.060.080.08
Filed Iscr0.440.710.70
Paid Up Equity Capital22.422.422.422.4
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.